Xolegel

Xolegel is a brand name of ketoconazole topical, approved by the FDA in the following formulation(s):

XOLEGEL (ketoconazole - gel; topical)

• 
  Manufacturer: AQUA PHARMS
  
  Approval date: July 28, 2006
  
  Strength(s): 2% ^[RLD]

Has a generic version of Xolegel been approved?

No. There is currently no therapeutically equivalent version of Xolegel available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Xolegel. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.

• 
  Anhydrous topical skin preparations
  Patent 7,179,475
  Issued: February 20, 2007
  Inventor(s): Burnett; Katherine M. & Kurtz; Ellen S.
  Assignee(s): Johnson & Johnson Consumer Companies, Inc.
  The present invention provides anhydrous compositions for topical delivery of a medicament comprising (A) a penetration enhancer/solvent selected from the group consisting of alcohol, propylene glycol, or a combination thereof; (B) a humectant/solvent selected from the group consisting of polyethylene glycol, glycerin, sorbitol, xylitol, or any combination of any of the foregoing; and (C) an anhydrous vehicle. In an alternate embodiment, the present invention provides anhydrous compositions for topical delivery of a medicament which comprise (A) a penetration enhancer/solvent selected from the group consisting of alcohol, propylene glycol, or a combination thereof; (B) a humectant/solvent selected from the group consisting of polyethylene glycol, glycerin, sorbitol, xylitol or any combination of any of the foregoing; (C) an anhydrous vehicle; and (D) a medicament. Also provided are methods for topically delivering a medicament to an animal, such as a mammal or a human patient, in need of the medicament by topically administering to the animal the compositions of the present invention.
  
  Patent expiration dates:
  
  
  • December 4, 2018
    
    ✓ 
    Patent use: TREATMENT OF SEBORRHEA DERMATITIS IN HUMANS
    ✓ 
    Drug product
  
  

See also...

• Xolegel Consumer Information (Drugs.com)
• Xolegel Gel Consumer Information (Wolters Kluwer)
• Xolegel Consumer Information (Cerner Multum)
• Xolegel Topical Advanced Consumer Information (Micromedex)
• Ketoconazole Cream Consumer Information (Wolters Kluwer)
• Ketoconazole Foam Consumer Information (Wolters Kluwer)
• Ketoconazole Gel Consumer Information (Wolters Kluwer)
• Ketoconazole Shampoo Consumer Information (Wolters Kluwer)
• Ketoconazole topical Consumer Information (Cerner Multum)
• Ketoderm Topical Advanced Consumer Information (Micromedex)
• Ketoconazole Topical Advanced Consumer Information (Micromedex)
• Ketoconazole topical AHFS DI Monographs (ASHP)